CVS HEALTH Corp (CVS) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — CVS

Balance Sheet

(in billions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	11.33	9.54	9.10	11.79	10.08	6.88	12.51	9.80	13.04	13.81	14.62	17.20	12.12	8.44	9.83	7.12	5.60
Short-term Investments	2.63	2.26	2.13	2.39	2.58	2.81	3.76	3.29	3.15	3.08	3.10	2.79	2.88	2.90	3.02	3.01	3.19
Accounts Receivable	40.31	40.99	43.86	40.65	39.63	36.18	32.39	32.22	32.93	29.55	28.33	26.32	27.23	26.45	25.28	24.16	23.86
Inventory	17.62	17.77	18.96	17.45	17.39	17.65	16.07	16.35	17.95	17.29	18.26	18.06	17.38	18.16	17.40	16.98	17.62
Total Current Assets	75.35	74.82	77.11	75.65	73.19	67.34	69.95	67.47	70.14	67.76	68.71	68.34	62.14	61.48	60.84	56.56	55.72
Property, Plant & Equipment	13.17	13.04	12.84	12.83	12.86	12.73	13.03	13.04	13.02	13.00	12.87	12.63	12.76	12.84	12.77	12.66	12.61
Goodwill	85.48	85.48	85.48	91.20	91.20	91.27	91.27	91.27	91.26	91.26	84.06	78.09	78.56	79.06	79.12	79.55	79.55
Intangible Assets	24.64	25.07	25.98	26.22	26.57	27.82	28.31	28.77	29.62	30.12	26.37	25.16	28.14	28.54	29.55	30.08	30.64
Total Non-current Assets*	178.42	178.16	178.22	182.69	182.39	185.08	182.53	182.27	181.16	182.32	170.62	162.87	168.14	171.39	174.05	174.61	173.89
Total Assets	253.77	252.97	255.33	258.34	255.59	252.43	252.48	249.74	251.31	250.07	239.33	231.21	230.28	232.87	234.89	231.16	229.61
Short-term Debt	--	--	1.25	3.04	1.26	0.80	0.00	2.72	--	1.00	--	--	--	--	--	--	0.25
Total Current Liabilities	87.04	86.41	92.70	94.16	88.96	84.63	81.39	83.32	81.55	79.21	75.05	72.41	68.46	69.78	64.71	59.31	60.10
Long-term Debt	59.45	60.53	60.51	57.29	59.04	59.82	62.64	57.69	59.78	61.42	56.45	50.85	50.80	52.06	56.83	59.29	59.27
Total Non-current Liabilities*	86.83	88.93	89.52	86.63	89.51	92.69	95.98	92.27	95.24	97.86	92.70	87.79	86.32	88.95	95.56	98.29	98.34
Total Liabilities	173.87	175.34	182.22	180.79	178.48	177.32	177.37	175.59	176.80	177.07	167.75	160.20	154.77	158.73	160.27	157.60	158.44
Retained Earnings	65.40	63.28	59.11	63.94	63.77	62.04	62.80	61.87	60.34	58.87	57.75	54.57	58.71	56.49	54.26	53.33	51.20
Total Stockholder Equity	79.70	77.46	72.93	77.38	76.93	74.94	74.93	73.97	74.34	72.73	71.38	70.68	75.18	73.83	74.31	73.24	70.85

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	106.10	100.43	105.69	102.87	98.92	94.59	97.71	95.43	91.23	88.44	93.81	89.76	88.92	85.28	83.85	81.16	80.64	76.83	76.60	73.79
Cost of Revenue	58.86	55.44	59.06	57.05	54.01	51.06	55.27	52.95	50.00	48.07	57.42	54.69	53.54	51.46	51.73	50.37	49.29	45.51	46.38	45.01
Gross Profit	47.23	44.98	46.63	45.83	44.91	43.53	42.44	42.48	41.24	40.36	36.39	104.28	35.39	33.82	32.12	30.79	31.35	31.32	30.23	28.78
Total Operating Expenses	42.53	40.30	44.52	49.03	42.53	40.16	40.07	41.65	38.19	38.09	33.02	93.91	32.15	30.38	64.06	34.73	9.17	9.88	59.60	25.72
Operating Income	4.70	4.68	2.11	(3.21)	2.38	3.37	2.37	0.83	3.05	2.27	3.37	3.69	3.23	3.45	3.62	(3.93)	4.57	3.49	2.23	3.06
Interest Expense	--	--	--	--	--	--	--	--	--	0.72	0.69	0.69	0.69	0.59	0.55	0.57	0.58	0.59	0.61	0.60
Pretax Income	3.98	3.94	1.35	(3.48)	1.65	2.62	2.13	0.11	2.34	1.58	2.71	3.02	2.57	2.88	3.11	(4.46)	4.03	2.95	1.57	2.15
Tax Provision	0.98	0.98	(1.57)	0.51	0.63	0.84	0.50	0.03	0.57	0.46	0.66	0.75	0.66	0.74	0.81	(1.05)	1.07	0.63	0.27	0.56
Net Income	2.98	2.94	2.94	(3.97)	1.02	1.78	1.64	0.09	1.77	1.11	2.05	2.26	1.90	2.14	2.30	(3.42)	2.95	2.31	1.31	1.60
Basic EPS	2.33	2.31	2.31	(3.13)	0.81	1.41	1.31	0.07	1.41	0.88	1.59	1.76	1.48	1.66	1.75	(2.60)	2.25	1.76	0.99	1.21
Diluted EPS	2.31	2.30	2.31	(3.13)	0.80	1.41	1.30	0.07	1.41	0.88	1.59	1.75	1.48	1.65	1.77	(2.60)	2.23	1.74	0.97	1.20

Cash Flow Statement

(in billions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	6.35	4.25	3.39	0.80	1.90	4.56	1.86	(0.74)	3.09	4.90	(2.64)	2.72	5.91	7.44	(1.95)	9.12	5.44	3.56	4.01	5.52
Capital Expenditures	0.69	0.85	0.78	0.70	0.61	0.74	0.77	0.67	0.64	0.71	0.91	0.55	0.59	0.98	0.69	0.58	0.41	1.05	0.60	0.61
Free Cash Flow*	5.65	3.40	2.61	0.10	1.29	3.81	1.09	(1.41)	2.45	4.20	(3.55)	2.17	5.32	6.45	(2.64)	8.54	5.04	2.51	3.41	4.91
Investing Cash Flow	(1.88)	(0.87)	(2.00)	(2.09)	(1.02)	(0.76)	(0.55)	(3.35)	(1.62)	(2.09)	(1.24)	(0.77)	(10.36)	(8.51)	(0.12)	(0.80)	(2.13)	(1.99)	(1.44)	(0.85)
Financing Cash Flow	(2.69)	(2.32)	(2.03)	(1.38)	0.81	(2.33)	0.43	(1.59)	1.25	(1.23)	(0.97)	(2.70)	3.63	2.73	(2.19)	(3.22)	(2.46)	(2.65)	(2.83)	(1.97)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Dividends Per Share	0.67	0.67	0.67	0.67	0.67	0.67	0.67	0.67	0.67	0.67	0.61	0.61	0.61	0.61	0.55	0.55	0.55	0.55	0.50	0.50